Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/17368
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDobrovic, Alexander-
dc.date2018-01-16-
dc.date.accessioned2018-04-05T00:23:55Z-
dc.date.available2018-04-05T00:23:55Z-
dc.date.issued2018-03-06-
dc.identifier.citationAnnals of internal medicine 2018; 168(5): 365-366-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/17368-
dc.language.isoeng-
dc.titleWhite Blood Cell BRCA1 Promoter Methylation Status and Ovarian Cancer Risk: A Perspective.-
dc.typeJournal Article-
dc.identifier.journaltitleAnnals of internal medicine-
dc.identifier.affiliationOlivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia-
dc.identifier.affiliationLa Trobe University, Bundoora, Victoria, Australia-
dc.identifier.affiliationThe University of Melbourne, Parkville, Victoria, Australia-
dc.identifier.doi10.7326/M17-3340-
dc.identifier.orcid0000-0003-3414-112X-
dc.identifier.pubmedid29335711-
dc.type.austinJournal Article-
local.name.researcherDobrovic, Alexander
item.grantfulltextnone-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
crisitem.author.deptSurgery (University of Melbourne)-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

12
checked on Nov 18, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.